The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a ...
In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has proposed a streamlined ...
July 10 (Reuters) - The U.S. FDA on Friday proposed a rule to streamline registration requirements for certain drug ...
The U.S. FDA on Friday proposed a rule to streamline registration requirements for certain drug manufacturers that operate through a central hub and multiple production facilities, as part of its ...
The U.S. FDA has proposed a rule to streamline registration for certain distributed drug manufacturing sites and clarify reporting requirements for some foreign production facilities, as part of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results